Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Plakin Family Autoantibodies in Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation As Useful Biomarkers and the Target for Rituximab Therapy

Eri Nishikawa, MD PhD, Yoshinao Muro, MD PhD, Nozomu Kawashima, MD PhD, Shinsuke Kataoka, MD, Motoharu Hamada, MD, Daisuke Ichikawa, MD, Daiei Kojima, MD, Norihiro Murakami, MD, Kyogo Suzuki, MD, Yuko Sekiya, MD, Yusuke Okuno, MD PhD, Rieko Taniguchi, MD, Atsushi Narita, MD PhD, Hideki Muramatsu, MD PhD, Nobuhiro Nishio, MD PhD, Asahito Hama, MD PhD, Seiji Kojima, MD PhD, Masashi Akiyama, MD PhD, Yoshiyuki Takahashi, MD PhD

Blood (2016) 128 (22): 3432.

https://doi.org/10.1182/blood.V128.22.3432.3432

Published: 2016

Journal Articles

Acute Bone Marrow GvHD Is Associated With Delayed B Cell Neogenesis and Impaired Natural Antibody Response After Allogeneic Hematopoietic Stem Cell Transplantation

Angela Mensen, Korinna Jöhrens, Ioannis Anagnostopoulos, Sonya Demski, Christoph Ochs, Philipp Hemmati, MD, Giang Lam Vuong, MD, Kathrin Rieger, Olga Blau, Jörg Westermann, MD, Bernd Dörken, Carmen Scheibenbogen, Renate Arnold, Il-Kang Na

Blood (2013) 122 (21): 4605.

https://doi.org/10.1182/blood.V122.21.4605.4605

Published: 2013

Journal Articles

Paraneoplastic Pemphigus (PNP) As a Presenting Finding in a Patient with Hodgkin's Lymphoma

Philip Marjon, MD, Byung Kim, MD, Tamara Lazic, MD, Christina Cernik, MD, Ritesh Rathore, MD

Blood (2011) 118 (21): 4864.

https://doi.org/10.1182/blood.V118.21.4864.4864

Published: 2011

Journal Articles

Early Results of Pentostatin, Cytoxan, Rituximab (PCR) Followed by CAMPATH-H (CA) for the Treatment of Relapse/Refractory Chronic Lymphocytic Leukemia (CLL) in ECOG Protocol E2903.

Sanford Kempin, MD, N.E. Kay, MD, Z. Sun, PhD, C. Secreto, BS, R.C. Tschumper, BS, D.F. Jelinek, PhD, S. Smoley, BS, D. Van Dyke, PhD, J. Saltzman, MD, S. Rosen, MD, M.S. Tallman, MD

Blood (2007) 110 (11): 3109.

https://doi.org/10.1182/blood.V110.11.3109.3109

Published: 2007

Journal Articles

Alemtuzumab (ALZ) Is an Effective Treatment for Both Primary and Relapsed Severe Paraneoplastic Pemphigus (PNP) Associated to B-Cell Chronic Lymphocytic Leukemia (CLL).

Rikke Bech, MD, Jane Baumgartner-Nielsen, MD, N.A. Peterslund, MD, Torben Steiniche, MD, Karen Bang, MD, Mette Deleuran, MD, Francesco d’Amore, MD

Blood (2007) 110 (11): 4716.

https://doi.org/10.1182/blood.V110.11.4716.4716

Published: 2007

Journal Articles

Chronic Lymphocytic Leukemia Complicated with Paraneoplastic Pemphigus and Glomerulonephritis in a Patient and Its Treatments: Report of One Case.

Qian Si Xuan, Li Jian Yong, Hong Ming, Changgeng Ruan, MD.

Blood (2007) 110 (11): 4725.

https://doi.org/10.1182/blood.V110.11.4725.4725

Published: 2007

NARROW

Plakin Family Autoantibodies in Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation As Useful Biomarkers and the Target for Rituximab Therapy

Acute Bone Marrow GvHD Is Associated With Delayed B Cell Neogenesis and Impaired Natural Antibody Response After Allogeneic Hematopoietic Stem Cell Transplantation

Paraneoplastic Pemphigus (PNP) As a Presenting Finding in a Patient with Hodgkin's Lymphoma

Early Results of Pentostatin, Cytoxan, Rituximab (PCR) Followed by CAMPATH-H (CA) for the Treatment of Relapse/Refractory Chronic Lymphocytic Leukemia (CLL) in ECOG Protocol E2903.

Alemtuzumab (ALZ) Is an Effective Treatment for Both Primary and Relapsed Severe Paraneoplastic Pemphigus (PNP) Associated to B-Cell Chronic Lymphocytic Leukemia (CLL).

Chronic Lymphocytic Leukemia Complicated with Paraneoplastic Pemphigus and Glomerulonephritis in a Patient and Its Treatments: Report of One Case.

Email alerts

ASH Publications

American Society of Hematology

Plakin Family Autoantibodies in Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation As Useful Biomarkers and the Target for Rituximab Therapy

Acute Bone Marrow GvHD Is Associated With Delayed B Cell Neogenesis and Impaired Natural Antibody Response After Allogeneic Hematopoietic Stem Cell Transplantation

Paraneoplastic Pemphigus (PNP) As a Presenting Finding in a Patient with Hodgkin's Lymphoma

Early Results of Pentostatin, Cytoxan, Rituximab (PCR) Followed by CAMPATH-H (CA) for the Treatment of Relapse/Refractory Chronic Lymphocytic Leukemia (CLL) in ECOG Protocol E2903.

Alemtuzumab (ALZ) Is an Effective Treatment for Both Primary and Relapsed Severe Paraneoplastic Pemphigus (PNP) Associated to B-Cell Chronic Lymphocytic Leukemia (CLL).

Chronic Lymphocytic Leukemia Complicated with Paraneoplastic Pemphigus and Glomerulonephritis in a Patient and Its Treatments: Report of One Case.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only